ipragliflozin l-proline
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
1 FDA-registered drug labeler
Maithri Drugs Private Limited
Why It Matters
Sectors
Health
Downstream UsesNo data available
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS951382-34-6
PubChem CID57339444
DTXSIDDTXSID20241771
FormulaC26H30FNO7S
Mol. Weight519.6 g/mol
SMILESC1CC(NC1)C(=O)O.C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)F
Data Sources
573394442026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/ipragliflozin l-proline/cids/JSON
Archive: data/sources/pubchem_name/ipragliflozin l-proline.json
CAS 951382-34-62026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json